NASDAQ · OPXSHealthcareOptical Instruments

Optex Systems Holdings financials

$10.55+0.96%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

QuarterQ3 '26
Jun 28
Q2 '26
Mar 29
Q1 '26
Dec 28
Q4 '25
Sep 28
Q3 '25
Jun 29
Q2 '25
Mar 30
Q1 '25
Dec 29
Q4 '24
Sep 29
Q3 '24
Jun 30
Q2 '24
Mar 31
Q1 '24
Dec 31
Q4 '23
Oct 1
Revenue$9.7M$9.6M$9.1M$11.3M$11.1M$10.7M$8.2M$9.4M$9.1M$8.5M$7.0M$8.1M
Gross profit$3.3M$3.4M$2.1M$3.4M$3.2M$3.4M$2.1M$2.4M$2.9M$2.6M$1.7M$2.6M
Gross margin34.2%35.2%22.9%30.1%28.5%31.3%26.0%25.5%31.8%30.0%24.2%32.6%
Operating income$1.4M$1.7M$149.0K$1.3M$1.9M$2.2M$916.0K$1.3M$1.6M$1.4M$553.0K$1.7M
Net income$1.3M$1.3M$242.0K$1.0M$1.5M$1.8M$844.0K$1.0M$1.3M$1.1M$431.0K$1.4M
Net margin13.2%13.9%2.6%9.1%13.6%16.5%10.3%10.7%13.9%12.5%6.2%17.7%
Diluted EPS$0.18$0.19$0.03$0.15$0.22$0.26$0.12$0.15$0.18$0.16$0.06$0.21
EBITDA$1.5M$1.8M$239.0K$2.2M$2.0M$2.4M$1.0M$1.4M$1.7M$1.5M$645.0K$1.8M
Operating cash flow$2.3M-$1.2M-$92.0K$1.6M$1.4M$1.2M$2.8M$753.0K$50.0K-$1.3M$2.3M$1.1M
Free cash flow$2.1M-$1.6M-$548.0K$1.5M$1.4M$1.1M$2.5M$545.0K-$256.0K-$1.4M$2.2M$1.1M
Diluted shares6.9M6.9M7.0M7.0M6.9M6.9M6.9M6.9M6.9M6.8M6.7M6.7M

Balance sheet

Period endJun 28Mar 29Dec 28Sep 28Jun 29Mar 30
Cash & equivalents$6.2M$4.2M$5.8M$6.4M$4.9M$3.5M
Short-term investments$0.00$0.00$0.00$0.00$0.00$0.00
Total debt$0.00$0.00$0.00$0.00$0.00$0.00
Total assets$32.5M$30.9M$30.2M$30.1M$29.2M$27.5M
Total liabilities$4.7M$4.6M$5.5M$5.8M$6.0M$5.9M
Shareholders' equity$27.7M$26.3M$24.7M$24.3M$23.1M$21.6M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology